AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump.
about
Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibioticsModel system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutationCarbapenems in the USA: focus on doripenem.Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamasesAntagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa.Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand.Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.Metallo-β-lactamase-production in meropenem-susceptible Pseudomonas aeruginosa isolates: risk for silent spread.Expression of ampC, oprD, and mexA, outer membrane protein analysis and carbapenemases in multidrug resistant clinical isolates of Pseudomonas aeruginosa from Egypt.
P2860
Q28493162-60BAB4F1-C07E-42A4-A42F-15BA5406A187Q34680522-8FD10072-023D-4100-9E41-64F0F9D9EA48Q35007624-EF9F1B79-863B-4AC5-99CD-5B80D43386DAQ35482558-CDCCCB31-50E4-4C7E-8975-DD493BA3177FQ36295397-3D1B95A3-39A8-4164-BF76-2938D7C29F85Q36960048-846C2AB7-D996-4C2F-8F58-AEA56CB0AB04Q37144824-4BA1CF78-A7C2-4CE5-9808-E8B6B0D3ED19Q38626934-ACFEA23D-65C3-463A-9BCE-D57D6C45FF87Q42063967-1CE21F74-C615-4861-9119-D7D3784F9DC3Q42131963-CFDD27F3-3E0C-4CE4-88BE-AEBD75A06DE5Q43194393-07C3CF69-5C30-48B6-925E-229240DC0BC9Q44222331-C48B7DD3-CE62-46EF-9CFC-E1D8AB2E032CQ46608208-43F09266-C72E-4648-AEA6-D80F523609B8Q50910400-5D7EFC24-9CA2-4AD9-B817-CD1D5C746787Q53842280-558D0C9F-6103-4D6B-9367-25685B70D487
P2860
AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
AmpC and OprD are not involved ...... ng the mexCD-oprJ efflux pump.
@en
AmpC and OprD are not involved ...... ng the mexCD-oprJ efflux pump.
@nl
type
label
AmpC and OprD are not involved ...... ng the mexCD-oprJ efflux pump.
@en
AmpC and OprD are not involved ...... ng the mexCD-oprJ efflux pump.
@nl
prefLabel
AmpC and OprD are not involved ...... ng the mexCD-oprJ efflux pump.
@en
AmpC and OprD are not involved ...... ng the mexCD-oprJ efflux pump.
@nl
P2093
P2860
P1476
AmpC and OprD are not involved ...... ng the mexCD-oprJ efflux pump.
@en
P2093
Daniel J Wolter
Nancy D Hanson
Philip D Lister
P2860
P304
P356
10.1128/AAC.49.11.4763-4766.2005
P407
P577
2005-11-01T00:00:00Z